BMY
Bristol-Myers Squibb Company
NYSE · USD · Stock
$62.48
-0.38 (-0.60%)
past month
Closed- Market cap
- $127.71B
- P/E
- 13.85
- Yield
- 4.03%
- Volume
- 12.7M
- 52 weeks
- $45.27 – $68.64
- Dividend
About
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications.
Bristol-Myers Squibb Company (BMY) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $45.27 and $68.64, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - General
- Princeton, United States
- 32.5K employees
- Led by Christopher S. Boerner Ph.D.
Coming up
Dividend paid
To owners on the ex-dividend day
Financials
Revenue, last 12 months
$50.03B+6.90%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+4.57%
Q1 2026
+11.18%
Q2 2026
+27.74%
Q3 2026
+14.91%
Earnings per share, last 12 months $4.51
Analysts
23 analysts say
Buy
12-month target$65.30+4.52%
Dividends
Yield · per share, yearly
4.03%$2.52
Ownership
- Institutions
- 84.78%
- Insiders
- 0.10%
Latest insider trade Oct 2, 2026, GALLMAN CARI
Prices from Yahoo Finance, may be delayed